Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 4;14(1):99.
doi: 10.1186/s13023-019-1075-8.

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Affiliations

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Liese Vandeborne et al. Orphanet J Rare Dis. .

Abstract

Background: Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient's family. Low rare disease awareness among physicians is believed to be one of the reasons for these late and misdiagnoses of rare disease patients. The aim of this study was to investigate how information and education could be tailored to the needs and preferences of physicians in Belgium to increase their rare disease awareness and support them in diagnosing patients with a rare disorder. Nine exploratory interviews with Belgian rare disease experts were performed in December 2016 to help the development of a questionnaire on information needs of physicians and their consulted information sources in rare disease awareness and diagnosis. This online questionnaire was then completed by Belgian physicians (n = 295), including general practitioners (GPs), pediatricians and other specialists (i.e. neurologists, pediatric neurologists, endocrinologists and pediatric endocrinologists) during January and February 2017.

Results: Rare disease knowledge and awareness were the lowest among GPs and the highest among specialists. Interviewed experts indicated that physicians' academic and continuous medical education should be focused more on "red flags" to increase rare disease attentiveness in daily clinical practice. GPs scored their academic education on rare diseases as insufficient but pediatricians and other specialists scored it significantly better (p < 0.001). Even though GPs declared to only need information on rare diseases when having a rare disease patient in their practice, specialists indicated to need more rare disease information in general. Most physicians confirmed that they had specific information needs regarding rare diseases. Unlike specialists, the majority of GPs were unaware of information sources such as Orphanet.

Conclusion: In order to effectively support physicians in Belgium to diagnose rare diseases early, the academic medical education on rare diseases should be revised. Teaching methods should be focused more on casuistry and "red flags". An Orphanet-like digital platform about rare disease symptoms, diagnostic tests and reference centers might be ideal to support correct and timely diagnosis.

Keywords: Diagnosis; Information needs; Orphanet; Physicians; Rare diseases; Red flags.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study, with protocol number S59783, was approved by the Medical Ethics Committee of UZ KU Leuven/Research on the 30th of November 2016. Informed consent was obtained from all participants, including interviewed experts and physicians that completed the questionnaire.

Consent for publication

Not applicable.

Competing interests

All authors declare that they have no competing interests. All authors read and approved the final manuscript. Pfizer nv/sa was not a sponsor of the study but provided support to Liese Vandeborne with access to their infrastructure, expertise and statistical aid during the conduct of this study. No undue influence from Pfizer nv/sa was experienced on the presented work, and Pfizer nv/sa did not receive any data obtained in this study.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Physicians’ self-evaluated level of rare disease knowledge. Response options for the question ‘How do you assess your own knowledge about rare diseases?’ ranged from 1 (‘Poor’) to 5 (‘Excellent’); 2 = ‘Substandard’, 3 = ‘Average’ and 4 = ‘Good’. Statistical analysis was performed with Mantel-Haenszel Chi2 Test: *, significant different distribution of responses (p < 0.05) from this physician group compared to those from all other physician groups; **, significant different distribution of responses (p < 0.05) from SP adult compared to GP and PED while no difference with SP child was detected; ***, significant different distribution of responses (p < 0.05) from SP child compared to GP and PED while no difference with SP adult was detected. PED = pediatrician. SP adult = specialists treating adults (endocrinologists and neurologists). SP child = specialists treating children (pediatric endocrinologists and neurologists)
Fig. 2
Fig. 2
Physicians’ self-evaluated level of rare disease awareness. Response options for the question ‘Are you aware of rare diseases?’ ranged from 1 (‘Absolutely not’) to 5 (‘Definitely, yes’); 2 = ‘Poorly aware’, 3 = ‘Moderately aware’ and 4 = ‘Well aware’. Statistical analysis was performed with Mantel-Haenszel Chi2 Test: *, significant different distribution of responses (p < 0.001) from this physician group compared to those from all other physician groups; **, significant different distribution of responses (p < 0.05) from PED compared to GP and SP child while no difference with SP adult was detected; ***, significant different distribution of responses (p < 0.05) from SP child compared to GP and PED while no difference with SP adult was detected. PED = pediatrician. SP adult = specialists treating adults (endocrinologists and neurologists). SP child = specialists treating children (pediatric endocrinologists and neurologists)
Fig. 3
Fig. 3
Physicians’ evaluation of the usefulness of their academic training for diagnosing rare diseases in daily practice. Response options for the question ‘How useful was your academic medical education for diagnosing rare diseases in daily practice?’. Full response options: very useful, I’m sure of myself when encountering rare diseases; sufficiently, I have got sufficient knowledge and training to diagnose rare disease patients; moderate, my academic medical training did not prepare me perfectly regarding rare disease diagnosis; insufficiently, I’d rather refer the patient to another specialist-doctor; not useful at all, the academic medical training did not prepare me concerning rare diseases. Statistical analysis was performed with Mantel-Haenszel Chi2 Test: *, significant different distribution of responses (p ≤ 0.001) from this physician group compared to those from all other physician groups. PED = pediatrician. SP adult = specialists treating adults (endocrinologists and neurologists). SP child = specialists treating children (pediatric endocrinologists and neurologists)

References

    1. De Sadeleer H. De zorg voor het kind door de huisarts en de pediater [dissertation] Ghent: University of Ghent; 2016.
    1. McIntyre FL. One in a million: when extraordinary cases occur in an ordinary practice. J Fam Pract. 1993;36(1):17–18. - PubMed
    1. Cello Health . Rare disease: taking a different approach. 2016.
    1. Garcia-Ribes M, Ejarque I, Arenas E, Martin V. New challenges: general practitioners faced with “rare diseases”. Aten Primaria. 2006;37(7):369–370. doi: 10.1157/13087370. - DOI - PMC - PubMed
    1. Kole A, Faurisson F, Mavris M. The voice of 12,000 patients. Experiences and expectations of rare disease patients on diagnosis and Care in Europe. Paris: EURORDIS; 2009.

Grants and funding